Clinical Cancer Research Grants Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Espinosa, A. B.
Right arrow Articles by Orfao, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Espinosa, A. B.
Right arrow Articles by Orfao, A.
Clinical Cancer Research Vol. 12, 772-780, February 2006
© 2006 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

The Cytogenetic Relationship between Primary and Recurrent Meningiomas Points to the Need for New Treatment Strategies in Cases at High Risk of Relapse

Ana Belén Espinosa1, María Dolores Tabernero1, Angel Maíllo2, José María Sayagués4, Juana Ciudad4, Marta Merino2, Maria Carmen Alguero1, Anne Marie Lubombo2, Pablo Sousa2, Angel Santos-Briz3 and Alberto Orfao4

Authors' Affiliations: 1 Unidad de Investigación, 2 Neurosurgery Service, and 3 Department of Pathology, Hospital Universitario de Salamanca and 4 Centro de Investigación del Cáncer, Cytometry General Service and Department of Medicine, University of Salamanca, Salamanca, Spain

Requests for reprints: Maria Dolores Tabernero Redondo, Hospital Universitario de Salamanca, Laboratorio Unidad de Investigación, Edificio Maternidad 2a Planta, Paseo de San Vicente 58-182, 37007 Salamanca, Spain. Phone: 34-923-29-12-30; Fax: 34-923-29-46-24; E-mail: taberner{at}usal.es.

Purpose: Recurrence is the major factor influencing the clinical outcome of meningioma patients although the exact relationship between primary and recurrent tumors still needs to be clarified. The aim of the present study is to analyze the cytogenetic relationship between primary and subsequent recurrent meningiomas developed within the same individual.

Experimental Design: Multicolor interphase fluorescence in situ hybridization was done for the identification of numerical abnormalities of 12 chromosomes in single-cell suspensions from 59 tumor samples corresponding to 25 recurrent meningioma patients. In 47 of these tumors, the distribution of different tumor cell clones was also analyzed in paraffin-embedded tissue sections. In parallel, 132 nonrecurrent cases were also studied.

Results: Most recurrent meningiomas showed complex cytogenetic aberrations associated with two or more tumor cell clones in the first tumor analyzed. Interestingly, in most individuals (74%), exactly the same tumor cell clones identified in the initial lesion were also detected in the subsequent recurrent tumor samples. In the recurrent tumor samples of the remaining cases (26%), we observed tumor cell clones related to those detected in the initial lesion but which had acquired one or more additional chromosome aberrations associated with either the emergence of new clones with more complex karyotypes or the disappearance of the most representative clones from the primary lesions. Multivariate analysis of prognostic factors showed that the Maillo et al. prognostic score, based on age of patient, tumor grade, and monosomy 14, together with tumor size was the best combination of independent variables for predicting tumor recurrence at diagnosis.

Conclusion: Overall, our results indicate that the development of recurrent meningiomas after complete tumor resection is usually due to regrowth of the primary tumor and rarely to the emergence of an unrelated meningioma, underlining the need for alternative treatment strategies in cases at high risk of relapse, particularly those with a high Maillo et al. prognostic score and larger tumors.




This article has been cited by other articles:


Home page
Neuro OncolHome page
A. Maillo, A. Orfao, A. B. Espinosa, J. M. Sayagues, M. Merino, P. Sousa, M. Lara, and M. D. Tabernero
Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone
Neuro-oncol, October 1, 2007; 9(4): 438 - 446.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
M. D. Tabernero, A. B. Espinosa, A. Maillo, O. Rebelo, J. F. Vera, J. M. Sayagues, M. Merino, P. Diaz, P. Sousa, and A. Orfao
Patient Gender Is Associated with Distinct Patterns of Chromosomal Abnormalities and Sex Chromosome Linked Gene-Expression Profiles in Meningiomas
Oncologist, October 1, 2007; 12(10): 1225 - 1236.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.